The second version of the BSI prospectus document ‘sustainable design and assessment of medicines, how do we define together?’ outlines the views of both health systems and manufacturers, while also citing drivers from the financial investment community.This document contains up to date information and a link for companies to sign up and get involved with the BSI work in this area.
For more info contact info@pagb.co.uk.
View more regulatory intelligence relating to medicines, medical devices and food supplements issues View our EU Exit blog here to stay on top of the latest from PAGB, Government, regulators and other stakeholders
Return to environment archive
